SION · Sionna Therapeutics, Inc. · Documents
$3.87
+0.18 (+4.88%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued. The Company believes that its existing cash, cash equivalents and marketable securities of $268.3 million as of June 30, 2026, will be sufficient to allow the Company to fund operations beyond twelve months from the date that the financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$165.93M
Shares
45.21M
Volume · Oct 27
1M
Avg daily vol (3M)
2.25M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-14 | 2026-09-09 | |
| 8-K | — | 2026-08-10 | — | |
| Investor Event Transcript | — | 2026-08-10 | 2026-09-30 | |
| 8-K | — | 2026-08-06 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | — | 2026-06-10 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-20 | 2026-06-30 | |
| 8-K | — | 2026-05-12 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| DEF 14A | — | 2026-04-27 | 2026-06-17 | |
| ARS | — | 2026-04-27 | 2025-12-31 | |
| DEFA14A | — | 2026-04-27 | — | |
| 8-K | — | 2026-03-02 | — | |
| 10-K | — | 2026-03-02 | 2025-12-31 | |
| S-3ASR | — | 2026-03-02 | — | |
| 8-K | — | 2025-11-05 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-08-11 | — | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-06-13 | 2025-06-12 | |
| 8-K | — | 2025-06-04 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEFA14A | — | 2025-04-29 | — | |
| DEF 14A | — | 2025-04-29 | 2025-06-12 | |
| 8-K | — | 2025-03-20 | — | |
| 10-K | — | 2025-03-20 | 2024-12-31 | |
| 8-K | — | 2025-02-10 | 2025-02-06 | |
| S-1/A | — | 2025-02-03 | — | |
| S-1 | — | 2025-01-17 | — |
Showing 1–33 of 33 filings
Key facts
CIK
2036042
CUSIP
829401108
13F (30d)
16 filings
16 filers
Visit website
Investor relations